Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Altimmune Inc’s current trading price is -61.25% away from its 52-week high, while its distance from the 52-week low is 49.14%. The
The stock market performance of Altimmune Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $11.16 on 11/13/24, while the lowest price during the same time frame was $2.90, recorded on 06/26/25. 52-week price history of ALT Stock
Altimmune Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $11.16 on 11/13/24, and the lowest price during that time was $2.90, recorded on 06/26/25. 52-week price history of ALT Stock A stock’s 52-week high and low prices
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 11.78%. However, over the past six months, we’ve seen a
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Altimmune Inc’s current trading price is -41.62% away from its 52-week high, while its distance from the 52-week low is 83.37%. The
Altimmune Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $11.16 on 11/13/24, while the lowest price for the same duration was marked at $3.55 on 04/08/25. 52-week price history of ALT Stock A
Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Altimmune Inc’s current trading price is -50.30% away from its 52-week high, while its distance from the 52-week low is
This month, markets have benefited from many comfort factors, beginning with the positive outcomes of many coronavirus vaccine trials, but also the approval by Donald Trump of the presidential transition, or the insistent reports of former Fed boss Janet Yellen as head of Joe Biden’s
All rights reserved © 2024, Powered By Smart TechOne